[18F]ODIBO: a prosthetic group for bioorthogonal radiolabeling of macromolecules via strain-promoted alkyne–azide cycloaddition
Literature Information
Mehdi Boudjemeline, Christopher D. McNitt, Thomas A. Singleton, Vladimir V. Popik, Alexey P. Kostikov
A novel prosthetic group for the efficient radiolabeling of macromolecules has been developed. [18F]oxadibenzocyclooctyne ([18F]ODIBO) is synthesized in high radiochemical yield and applied for nearly quantitative conjugation to azide-tagged peptides and proteins at room temperature and low substrate concentrations. The resulting bioconjugates are chemically and radiochemically pure and free of toxic solvents and catalysts.
Related Literature
Recyclable and efficient polyurethane-Ir catalysts for direct borylation of aromatic compounds
Akihiro Kimura, Haruka Hayama, Hassan Nageh, Yue Wang, Naofumi Naga
DOI: 10.1039/C7PY01509G
Synthesis of enzyme-responsive phosphoramidate dendrimers for cancer drug delivery
Zhen Zhang, Yongcun Zhou, Zhuxian Zhou, Ying Piao, Nagendra Kalva, Xiangrui Liu, Jianbin Tang, Youqing Shen
DOI: 10.1039/C7PY01492A
Ferromagnetic iron oxide–cellulose nanocomposites prepared by ultrasonication
Razvan Rotaru, Marcela Savin, Nita Tudorachi, Cristian Peptu, Petrisor Samoila, Liviu Sacarescu, Valeria Harabagiu
DOI: 10.1039/C7PY01587A
Main-chain benzoxazine precursor block copolymers
Zeynep Deliballi, Baris Kiskan, Yusuf Yagci
DOI: 10.1039/C7PY01873H
Significantly improved energy density of BaTiO3 nanocomposites by accurate interfacial tailoring using a novel rigid-fluoro-polymer
Sheng Chen, Xuguang Lv, Xianghui Han, Hang Luo, Chris R. Bowen, Dou Zhang
DOI: 10.1039/C7PY01914A
Thermoresponsive hybrid double-crosslinked networks using magnetic iron oxide nanoparticles as crossing points
Thomas Blin, Antoine Niederberger, Lazhar Benyahia, Jérôme Fresnais, Véronique Montembault, Laurent Fontaine
DOI: 10.1039/C8PY01006D
Synthesis of poly(ionic liquid)-based nano-objects with morphological transitions via RAFT polymerization-induced self-assembly in ethanol
Yongqi Yang, Jinwen Zheng, Shoukuo Man, Xiaolan Sun, Zesheng An
DOI: 10.1039/C8PY00040A
You might also like
What are the main uses of (3.beta.)-3-Hydroxy-N,N-dimethyl-chol-5-en-24-amide (CAS: 79066-03-8)?
(3.beta.)-3-Hydroxy-N,N-dimethyl-chol-5-en-24-amide (CAS: 79066-03-8) is primari...
What regulatory guidelines apply to 5-(aminomethyl)-2-methoxyphenol (CAS: 89702-89-6)?
5-(Aminomethyl)-2-methoxyphenol (CAS: 89702-89-6) is classified under GHS as a s...
What is Thieno[2,3-c]pyridin-7(6H)-one (CAS: 28981-13-7)?
Thieno[2,3-c]pyridin-7(6H)-one (CAS: 28981-13-7) is a heterocyclic organic compo...
Is 1-[(6-Methoxy-3-pyridinyl)methyl]-4-piperidinamine dihydrochloride (CAS: 1185311-28-7) safe?
1-[(6-Methoxy-3-pyridinyl)methyl]-4-piperidinamine dihydrochloride is generally ...
What regulatory guidelines apply to [(2E)-3-Phenyl-2-propen-1-yl]phosphonic acid (CAS: 146404-58-2)?
[(2E)-3-Phenyl-2-propen-1-yl]phosphonic acid (CAS: 146404-58-2) is regulated und...
What regulatory guidelines apply to 6-Bromo-7-methoxyquinoline (CAS: 1620515-86-7)?
6-Bromo-7-methoxyquinoline (CAS: 1620515-86-7) falls under the scope of the Glob...
What industries use (2R)-1-(1-Benzofuran-2-yl)-N-propyl-2-pentanamine (CAS: 260550-89-8)?
This compound is primarily used in the pharmaceutical industry for the developme...
What are the main uses of 1-Ethyl-7-[2-methyl-6-(4H-1,2,4-triazol-3-yl)-3-pyridinyl]-3,5-dihydropyrazino[2,3-b]pyrazin-2(1H)-one (CAS: 1228013-15-7)?
1-Ethyl-7-[2-methyl-6-(4H-1,2,4-triazol-3-yl)-3-pyridinyl]-3,5-dihydropyrazino[2...
Are there alternatives to {5-(Acryloylamino)-2-[(dimethylamino)methyl]phenyl}boronic acid (CAS: 1217500-78-1) in synthesis?
Alternative reagents such as 2-[(dimethylamino)methyl]phenylboronic acid or rela...
What is 3-(Piperidin-4-yloxy)pyridine (CAS: 310881-48-2)?
3-(Piperidin-4-yloxy)pyridine (CAS: 310881-48-2) is an organic compound with the...
Source Journal
Organic & Biomolecular Chemistry

Organic & Biomolecular Chemistry (OBC) publishes original and high impact research and reviews in organic chemistry. We welcome research that shows new or significantly improved protocols or methodologies in total synthesis, synthetic methodology or physical and theoretical organic chemistry as well as research that shows a significant advance in the organic chemistry or molecular design aspects of chemical biology, catalysis, supramolecular and macromolecular chemistry, theoretical chemistry, mechanism-oriented physical organic chemistry, medicinal chemistry or natural products. Articles published in the journal should report new work which makes a highly-significant impact in the field. Routine and incremental work is generally not suitable for publication in the journal. More details about key areas of our scope are below. In all cases authors should include in their article clear rationale for why their research has been carried out.











![7-Bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine structure 7-Bromo-5-chloro-1H-pyrazolo[4,3-b]pyridine structure](https://static.chemtradehub.com/structs/135/1351813-70-1-a716.webp)


